Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (982)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$564.81
Total Value
$722.95K
Shares Held After
44,273
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,949
Price
$563.97
Total Value
$1.10M
Shares Held After
45,553
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,071
Price
$562.94
Total Value
$1.17M
Shares Held After
47,502
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$562.01
Total Value
$247.28K
Shares Held After
49,573
% of Holdings
0.9%
FATE THERAPEUTICS INC (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
25,590
Price
$1.88
Total Value
$48.08K
Shares Held After
628,155
% of Holdings
3.9%
FATE THERAPEUTICS INC (FATE)
Valamehr Bahram — Director
Shares
28,946
Price
$1.88
Total Value
$54.48K
Shares Held After
635,762
% of Holdings
4.4%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
6,000
Price
$32.00
Total Value
$192.00K
Shares Held After
116,731
% of Holdings
4.9%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.30
Total Value
$1.53M
Shares Held After
1,123,095
% of Holdings
2.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
85,895
Price
$0.43
Total Value
$36.93K
Shares Held After
955,447
% of Holdings
8.2%
Serina Therapeutics, Inc. (SER)
Marshall Richard Peter — Director
Shares
12,183
Price
$1.65
Total Value
$20.10K
Shares Held After
12,183
% of Holdings
100.0%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
199
Price
$65.51
Total Value
$13.04K
Shares Held After
20,975
% of Holdings
0.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
200
Price
$0.95
Total Value
$190.00
Shares Held After
291,766
% of Holdings
0.1%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
444
Price
$65.51
Total Value
$29.09K
Shares Held After
75,045
% of Holdings
0.6%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200,000
Price
$1.50
Total Value
$299.80K
Shares Held After
800,000
% of Holdings
25.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200,000
Price
$1.56
Total Value
$312.08K
Shares Held After
600,000
% of Holdings
33.3%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
68,551
Price
$1.60
Total Value
$109.67K
Shares Held After
400,000
% of Holdings
17.1%
INCYTE CORP (INCY)
Clancy Paul J — Director
Shares
15,000
Price
$94.93
Total Value
$1.42M
Shares Held After
23,741
% of Holdings
38.7%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
662
Price
$3.01
Total Value
$2.00K
Shares Held After
677,977
% of Holdings
0.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Shares
384
Price
$3.01
Total Value
$1.16K
Shares Held After
89,780
% of Holdings
0.4%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,409
Price
$3.01
Total Value
$7.26K
Shares Held After
1,040,918
% of Holdings
0.2%
RenovoRx, Inc. (RNXT)
VOLL MARK — Chief Financial Officer
Shares
25,000
Price
$0.79
Total Value
$19.69K
Shares Held After
142,380
% of Holdings
17.6%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200
Price
$13.80
Total Value
$2.76K
Shares Held After
926,352
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
10,000
Price
$13.98
Total Value
$139.82K
Shares Held After
926,152
% of Holdings
1.1%
Liquidia Corp (LQDA)
Caligan Partners LP — Director
Shares
5,300
Price
$59.98
Total Value
$317.89K
Shares Held After
8,138,951
% of Holdings
0.1%
Liquidia Corp (LQDA)
Caligan Partners LP — Director
Shares
5,300
Price
$59.98
Total Value
$317.89K
Shares Held After
8,133,651
% of Holdings
0.1%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$58.65
Total Value
$1.47M
Shares Held After
1,148,095
% of Holdings
2.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
62,970
Price
$0.45
Total Value
$28.34K
Shares Held After
1,041,342
% of Holdings
5.7%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,200
Price
$1.68
Total Value
$3.70K
Shares Held After
3,529
% of Holdings
62.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$572.36
Total Value
$68.68K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
562
Price
$571.24
Total Value
$321.04K
Shares Held After
40,633
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,099
Price
$570.35
Total Value
$626.82K
Shares Held After
41,195
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,393
Price
$569.42
Total Value
$793.20K
Shares Held After
42,294
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,640
Price
$568.46
Total Value
$932.28K
Shares Held After
43,687
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,149
Price
$567.38
Total Value
$651.92K
Shares Held After
45,327
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,140
Price
$566.34
Total Value
$1.21M
Shares Held After
46,476
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,237
Price
$565.54
Total Value
$699.57K
Shares Held After
48,616
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
109
Price
$562.31
Total Value
$61.29K
Shares Held After
49,853
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
51
Price
$561.52
Total Value
$28.64K
Shares Held After
49,962
% of Holdings
0.1%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
9,120
Price
$6.37
Total Value
$58.09K
Shares Held After
700,000
% of Holdings
1.3%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
339
Price
$9.21
Total Value
$3.12K
Shares Held After
183,614
% of Holdings
0.2%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$75.69
Total Value
$264.92K
Shares Held After
153,902
% of Holdings
2.2%
Kura Oncology, Inc. (KURA)
FORD KATHLEEN — Chief Operating Officer
Shares
2,257
Price
$9.08
Total Value
$20.48K
Shares Held After
153,560
% of Holdings
1.4%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
27,116
Price
$9.01
Total Value
$244.25K
Shares Held After
1,535,082
% of Holdings
1.7%
Artiva Biotherapeutics, Inc. (ARTV)
Bush Jennifer — COO, CLO, Compliance Officer
Shares
8,790
Price
$9.01
Total Value
$79.18K
Shares Held After
337,920
% of Holdings
2.5%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
7,037
Price
$9.01
Total Value
$63.39K
Shares Held After
144,963
% of Holdings
4.6%
Artiva Biotherapeutics, Inc. (ARTV)
Horan Christopher — Chief Tech Operations Officer
Shares
7,002
Price
$9.01
Total Value
$63.07K
Shares Held After
293,450
% of Holdings
2.3%
Artiva Biotherapeutics, Inc. (ARTV)
Raymon Heather — SVP, Research and Development
Shares
3,095
Price
$9.01
Total Value
$27.88K
Shares Held After
148,228
% of Holdings
2.0%
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$9.17
Total Value
$568.54K
Shares Held After
1,387,695
% of Holdings
4.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
7,975
Price
$106.97
Total Value
$853.09K
Shares Held After
273,037
% of Holdings
2.8%
INSMED Inc (INSM)
Lewis William — Director
Shares
11,836
Price
$106.39
Total Value
$1.26M
Shares Held After
281,012
% of Holdings
4.0%
Showing 101–150 of 982 transactions (page 3 of 20)